As the lowest dose of EGCG in our findings could significantly affect both the memory and molecular changes seen in AD animals, it is reasonable to postulate that the memory deficits observed in AD rats may be in part due to the increased APP and decreased BDNF gene expression within the hippocampus of AD animals. Here, APP is linked to Alzheimer disease.